Press Releases

Newsroom
In the News
Press Releases
Resources for Journalists

Press Releases

Share
Share
and/or
497 News Releases found
David G. Pfister, MD (left) and Sabiha Raoof, MD (right)
Memorial Sloan Kettering Cancer Center and MediSys Health Network Announce New Collaboration to Enhance Cancer Care in Queens

Memorial Sloan Kettering Cancer Center and MediSys Health Network today announced a new collaboration that will expand access to world-class cancer care for the people of Queens and eastern Brooklyn.
MSK Awards & Appointments December 2022
MSK Awards & Appointments December 2022

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.
A rendering of Memorial Medical Care, PC
New Cancer Care Facility Opens in Brooklyn

Memorial Medical Care, PC, a practice of Memorial Sloan Kettering Cancer Center physicians, in collaboration with New York Cancer & Blood Specialists (NYCBS), recently announced the opening of a new comprehensive cancer care practice in the Flatbush section of Brooklyn.
MSK Awards & Appointments November 2022

Memorial Sloan Kettering Cancer Center (MSK) announces the November 2022 awards and appointments.
Jeffrey Zwicker, MD
Jeffrey Zwicker Joins Memorial Sloan Kettering Cancer Center as Chief of the Hematology Service

Jeffrey Zwicker, MD, has been named Chief of the Hematology Service at Memorial Sloan Kettering Cancer Center (MSK). He joins MSK from Harvard University Medical School, where he was an Associate Professor of Medicine, and Beth Israel Deaconess Medical Center (BIDMC), where he served as Chief of Benign Hematology in the Division of Hematology since 2017. Dr. Zwicker succeeds MSK’s Interim Hematology Service Chief, Marcel van den Brink, MD, PhD.
Physician reviewing electronic medical records.
Memorial Sloan Kettering Cancer Center Selects Epic to Transform Electronic Health Record System

Memorial Sloan Kettering Cancer Center announced it has selected Epic to provide a new platform for integrated care that will ensure patients and physicians can more easily access electronic health records.
Lawrence Schwartz, MD
Memorial Sloan Kettering Cancer Center Names Lawrence Schwartz, MD, New Chair of the Department of Radiology

Memorial Sloan Kettering Cancer Center (MSK) today announced the appointment of Lawrence Schwartz, MD, as MSK’s new Chair of the Department of Radiology. He will assume the role in early 2023. Dr. Schwartz is internationally recognized for his expertise in quantitative imaging, artificial intelligence in cancer imaging, and for his pioneering work in the development and validation of novel imaging biomarkers in oncology.
Memorial Sloan Kettering Cancer Center Tops Prestigious List of Highly Cited Researchers 2022
Memorial Sloan Kettering Cancer Center Tops Prestigious List of Highly Cited Researchers 2022

Memorial Sloan Kettering Cancer Center (MSK) is proud to announce that it is ranked among the top 15 organizations with the greatest number of highly cited scientific researchers worldwide, according to the annual list of Highly Cited Researchers published by the Institute for Scientific Information at Clarivate.
A Fred's Team runner
Fred's Team Makes History by Raising $100 Million for Cancer Research

Fred’s Team, MSK’s running program, has made history by surpassing $100 million in total funds raised for cancer research.
Eli L. Diamond, MD and Omar Abdel-Wahab, MD
FDA Approves Oral MEK Inhibitor Cobimetinib for Histiocytic Neoplasms, Research Led by Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center (MSK) announced today that the U.S. Food and Drug Administration (FDA) has approved the oral MEK inhibitor drug cobimetinib (COTELLIC®) for the treatment of adult patients with the family of blood diseases know as histiocytic neoplasms (HN). These diseases include: Erdheim-Chester Disease, Rosai-Dorfman, and Langerhans Histiocytosis. Cobimetinib is an oral inhibitor of MEK1 and MEK2 currently approved to treat melanoma.